Atlas Trials

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Clinical trial NCT00127049 · UNKNOWN

Trial details

NCT number
NCT00127049
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Germ Cell Tumor
Start date
2004-12-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.